BRIAN M. COGAN, District Judge.
Non-party Navidea Biopharmaceuticals, Inc. seeks an order lifting the litigation stay in this receivership case so that it may implead one of the companies in receivership in an action pending outside the receivership. Because the costs to the Receivership and resulting prejudice to other parties-in-interest outweigh the prejudice that Navidea might suffer from deferring its litigation, the motion is denied.
In 2012, Navidea, as borrower, and Platinum-Montaur Life Sciences LLC ("Platinum-Montaur"), as lender, entered into a loan agreement and related promissory note. At all relevant times, Platinum Partners Value Arbitrage Fund L.P. ("PPVA") was the holder of roughly 99% of the membership interests in Platinum-Montaur. In 2016, Platinum-Montaur assigned certain of its assets to Platinum Partners Credit Opportunities Master Fund LP ("PPCO"), including the right to payments due under the note.
At the end of 2016, the Securities and Exchange Commission filed this case, and the Court entered an Order placing PPCO into receivership, along with certain affiliated companies. Roughly about the same time, the Financial Services Division of the Grand Court of the Cayman Islands directed the winding up of PPVA, and appointed joint liquidators. PPVA, including Platinum-Montaur, is part of a separate group of entities, not part of this Court's receivership.
In February 2017, the Receiver made a demand on Navidea for it to repay the portion of the note owed to PPCO. At the same time, Platinum-Montaur demanded that Navidea repay a separate portion of the note.
After these two demands — from PPCO and Platinum-Montaur — Navidea repaid PPCO. The Repayment Agreement between Navidea and PPCO contained an indemnification provision, stating:
Navidea did not remit payment to Platinum-Montaur, and Platinum-Montaur has commenced an action to recover that portion of the note that it asserts is payable.
Navidea wrote to the Receiver, requesting that PPCO reimburse and indemnify it against all liabilities, including Platinum-Montaur's claim. The Receiver declined. Navidea therefore seeks to lift the litigation stay so to allow it to file a third-party complaint for indemnification against PPCO in the Platinum-Montaur litigation.
The parties agree on the factors the Court should consider in deciding whether to lift the stay:
The three-factor test "simply requires the district court to balance the interests of the Receiver and the moving party."
The parties disagree about the merits of Navidea's potential claim against PPCO, but the Court need not reach that issue. Navidea can only secure the ultimate relief it seeks (to the extent it has a meritorious claim) if Platinum-Montaur prevails against it in the currently pending litigation. If not, Navidea will suffer no loss for which PPCO might have an indemnification obligation. Rather than force the Receiver to engage in costly, time-consuming, distracting, and — most significantly — potentially unnecessary litigation, it makes more sense to wait and see the outcome of the currently pending litigation.
Navidea, too, will be no worse off for having to wait. Even if PPCO is found to have an indemnification obligation, Navidea does not argue that it is entitled to any kind of reimbursement at this time. In fact, the line of cases Navidea cites expressly say otherwise.
Navidea's uncertainty as to its potential future rights is not the kind of "substantial injury" that merits lifting the litigation stay. It does not come close to outweighing the costs to the Receivership in defending against Navidea's proposed action.